Resmed (Germany) Today
| RMEA Stock | EUR 23.60 0.40 1.72% |
Performance6 of 100
| Odds Of DistressLess than 9
|
Resmed is trading at 23.60 as of the 30th of November 2024. This is a 1.72 percent increase since the beginning of the trading day. The stock's lowest day price was 23.6. Resmed has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Resmed Inc DRC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of June 2024 and ending today, the 30th of November 2024. Click here to learn more.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company has 1.47 B outstanding shares. More on Resmed Inc DRC
Moving together with Resmed Stock
Moving against Resmed Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Resmed Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Resmed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Resmed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Resmed Inc DRC (RMEA) is traded on Frankfurt Exchange in Germany and employs 8,160 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 29.64 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Resmed's market, we take the total number of its shares issued and multiply it by Resmed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Resmed Inc DRC operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 1.47 B outstanding shares.
Resmed Inc DRC has accumulated about 147.13 M in cash with 351.15 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1.
Check Resmed Probability Of Bankruptcy
Ownership AllocationResmed owns a total of 1.47 Billion outstanding shares. Roughly 92.08 pct. of Resmed outstanding shares are held by general public with 7.92 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Resmed Ownership Details
Resmed Inc DRC Risk Profiles
Although Resmed's alpha and beta are two of the key measurements used to evaluate Resmed's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.21 | |||
| Semi Deviation | 1.18 | |||
| Standard Deviation | 1.54 | |||
| Variance | 2.38 |
Resmed Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Resmed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Resmed Corporate Management
Elected by the shareholders, the Resmed's board of directors comprises two types of representatives: Resmed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Resmed. The board's role is to monitor Resmed's management team and ensure that shareholders' interests are well served. Resmed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Resmed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy Wakeham | VP Communications | Profile | |
| Brett Sandercock | Chief Officer | Profile | |
| BE MBA | CEO Director | Profile | |
| Robert Douglas | Pres COO | Profile | |
| Vered Keisar | Chief Officer | Profile | |
| AM AM | Founder Chairman | Profile | |
| David Pendarvis | Global Officer | Profile |
Other Information on Investing in Resmed Stock
Resmed financial ratios help investors to determine whether Resmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resmed with respect to the benefits of owning Resmed security.